Somatoform Disorders Clinical Trial
Official title:
Treatment of Multi-organ Bodily Distress Syndrome. A Randomized Controlled Trial of the Effects of Acceptance and Commitment Therapy Given as Group Therapy or Workshop Compared to Standard Treatment (Stress-4)
The aim of this study is to test the effect of Acceptance and Commitment Therapy (ACT) in patients with long lasting health problems with no known medical explanation, defined as multi-organ Bodily distress syndrome (BDS). ACT treatment is given as two different types of treatment, a 9-session group therapy and a 1-day workshop followed by an individual consultation, and both are compared to standard treatment, which is one single advisory consultation. The study includes 180 patients.
The aim of this study is to test the effect of Acceptance and Commitment Therapy (ACT) in
patients with multi-organ Bodily distress syndrome (BDS). BDS is a unifying diagnosis that
encompasses a group of closely related conditions such as somatization disorder,
fibromyalgia, irritable bowel syndrome and chronic fatigue syndrome. The project consists of
a three-armed randomized controlled trial of ACT treatment given as a supplement to standard
treatment as either 9-session group therapy or as a 1-day workshop followed by an individual
consultation, compared to standard treatment, which is one single advisory consultation.
Primary outcome is patient-rated improvement measured by Clinical Global Improvement Scale
(CGI-I). Secondary outcome is functional level (physical, mental and social) measured by the
SF-36 Physical Component Summary (PCS). The study includes 180 participants.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00276887 -
Cognitive Behavior Therapy for Somatization Disorder
|
Phase 2 | |
| Enrolling by invitation |
NCT05565352 -
Observation of Ketamine Treatment Safety and Tolerability in Adult Psychiatry Clinic Medical University of Gdańsk Inpatients
|
||
| Active, not recruiting |
NCT04847310 -
Cost-benefit Evaluation of a Transdiagnostic Psychological Treatment for Emotional Disorders in Primary Care
|
N/A | |
| Completed |
NCT05611606 -
Welfare Benefits in Functional Somatic Disorders
|
||
| Completed |
NCT05631860 -
Psychological Risk Factors for Functional Somatic Disorders
|
||
| Completed |
NCT02151500 -
Stress and Health Interview for Primary Care Patients With Medically Unexplained Symptoms
|
N/A | |
| Completed |
NCT01590992 -
Treatment of Globus Sensations With Psychotherapy
|
N/A | |
| Completed |
NCT00149799 -
Effectiveness of Escitalopram in the Treatment of Body Dysmorphic Disorder
|
Phase 3 | |
| Completed |
NCT00368212 -
Integrated Treatment Program for Hypochondriasis in Primary Care Settings
|
Phase 3 | |
| Terminated |
NCT02843932 -
Subjective Perception of Motor Control During Psychogenic Disorders
|
N/A | |
| Terminated |
NCT03904784 -
School Withdrawal in Adolescents
|
||
| Recruiting |
NCT04807933 -
Neurovegetative Decoupling in Somatoform Disorders : Biofeedback Interest
|
N/A | |
| Completed |
NCT01119469 -
Comparing Cognitive Therapy and Exposure Therapy in Individuals With Hypochondriasis
|
Phase 3 | |
| Recruiting |
NCT03188861 -
Systematic Screening for Comorbid Psychological Conditions in Cardiac ACSC Patients With Multimorbidity in the ED
|
||
| Recruiting |
NCT04835103 -
Build a Research Clinic for Somatoform Patients
|
N/A | |
| Completed |
NCT02346071 -
Acceptance and Commitment Group Therapy for Adolescents With a Range of Functional Somatic Syndromes
|
N/A | |
| Completed |
NCT01518634 -
Imipramine Treatment for Patients With Multi-organ Bodily Distress Syndrome
|
Phase 2 | |
| Recruiting |
NCT01391897 -
Epigenetics of Posttraumatic Stress Disorder and Somatoform Disorders in the Course of Psychotherapy
|
N/A | |
| Completed |
NCT01924715 -
Evaluating the Cost Effectiveness of ISTDP: A Quasi Experimental Study
|
N/A | |
| Completed |
NCT00130988 -
DEPENAS: A Psychosocial Intervention for Patients With Medically Unexplained Symptoms
|
Phase 3 |